Literature DB >> 12084335

New insights and candidate genes and their implications for care of patients with hereditary prostate cancer.

H L Kim1, G D Steinberg.   

Abstract

A positive family history is a risk factor for prostate cancer. Most studies based on segregation analysis suggest autosomal dominant transmission of susceptibility genes. Multiple loci on chromosome 1 and chromosome X have been associated with prostate cancer by linkage analysis. The candidate gene approach has also revealed multiple genetic markers that are associated with increased risk for the disease. The genetic studies in prostate cancer suggest there are multiple genes involved in the development and progression of prostate cancer.

Entities:  

Mesh:

Year:  2000        PMID: 12084335     DOI: 10.1007/s11934-000-0029-x

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  50 in total

1.  Family history of prostate cancer: a multi-center case-control study in Canada.

Authors:  P Ghadirian; G R Howe; T G Hislop; P Maisonneuve
Journal:  Int J Cancer       Date:  1997-03-17       Impact factor: 7.396

2.  Re: Prostate cancer and the androgen receptor.

Authors:  G A Coetzee; R K Ross
Journal:  J Natl Cancer Inst       Date:  1994-06-01       Impact factor: 13.506

3.  Family history and the risk of prostate cancer.

Authors:  G D Steinberg; B S Carter; T H Beaty; B Childs; P C Walsh
Journal:  Prostate       Date:  1990       Impact factor: 4.104

4.  Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4.

Authors:  T R Rebbeck; J M Jaffe; A H Walker; A J Wein; S B Malkowicz
Journal:  J Natl Cancer Inst       Date:  1998-08-19       Impact factor: 13.506

5.  No difference in survival between sporadic, familial and hereditary prostate cancer.

Authors:  H Grönberg; L Damber; B Tavelin; J E Damber
Journal:  Br J Urol       Date:  1998-10

6.  The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer.

Authors:  R A Irvine; M C Yu; R K Ross; G A Coetzee
Journal:  Cancer Res       Date:  1995-05-01       Impact factor: 12.701

7.  Association of prostate cancer with vitamin D receptor gene polymorphism.

Authors:  J A Taylor; A Hirvonen; M Watson; G Pittman; J L Mohler; D A Bell
Journal:  Cancer Res       Date:  1996-09-15       Impact factor: 12.701

8.  Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate.

Authors:  L Harlan; O Brawley; F Pommerenke; P Wali; B Kramer
Journal:  J Clin Oncol       Date:  1995-01       Impact factor: 44.544

Review 9.  Familial prostate cancer in Sweden. A nationwide register cohort study.

Authors:  H Grönberg; L Damber; J E Damber
Journal:  Cancer       Date:  1996-01-01       Impact factor: 6.860

10.  Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer.

Authors:  X Gao; A Zacharek; A Salkowski; D J Grignon; W Sakr; A T Porter; K V Honn
Journal:  Cancer Res       Date:  1995-03-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.